Eli Lilly Files For FDA Emergency Use Of COVID-19 Antibody Treatment
Takeda 2020: The incredible growing/shrinking pharma
Sanofi 2020: New challenges
Pfizer 2020: Cancer and COVID-19
Roche 2020: Built for innovation
Inovio: COVID-19 Vaccine Trial Delay Is Disappointing, But Not a Deal Breaker, Says Analyst
White House Reverses Course, Approves New FDA COVID-19 Vaccine Guidelines
Eli Lilly to seek U.S. emergency use for Covid-19 treatment
Kindred Spikes 12% On Vaxart Vaccine Manufacturing Deal
FDA gives COVID-19 vaccine ‘advice’ after White House blocks guidance
Vir Biotechnology Kicks Off Covid-19 Treatment Trial; Shares Rise 6.1%
ChromaDex Pops 28% On Anti-Ageing Supplement Covid-19 Study
Exclusive Pharma Microbiology interview with Maria Jose Lopez Barragan, formerly at FDA
COVID-19 Outbreaks Worsen In NY, NJ & CT As Cuomo Outlines New Plan For Containing 'Hot Spots': Live Updates
White House Acquiesces To FDA's COVID-19 Vaccine Emergency-Approval Guidelines
New research supports sofosbuvir in combination with other antivirals for COVID-19
If COVID-19 Antibody 'Cocktails' Become Popular, Sorrento Stock Could Double, Says Analyst
FDA Outlines Requirements For "Emergency Use Authorization" Of COVID-19 Vaccine Amid Reports Of WH Interference
How the leading coronavirus vaccines work
NYC Schools Close As COVID-19 Makes "Dangerous Comeback" Across US: Live Updates
Race for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jab
J&J settles 1,000 talc lawsuits for $100m+; report
The 6 Degrees of Separating Coronavirus from President Trump
Gilead vs Pfizer: Which Healthcare Stock Has Stronger Prospects?
Covid-19 roundup: Top analyst: Regeneron EUA likely this week — unless Trump takes a turn for worse; UK says less than half of residents will be vaccinated
Trump’s Treatments: Regeneron’s Antibodies and Gilead’s Remdesivir Explained
Microchip'd? DARPA Biochip To "Save" Us From COVID Can Control Human DNA
Trump treated with experimental antibody cocktail for Covid-19
Trump Has "Low-Grade Fever, Nasal Congestion And A Cough"; Treated With Regeneron Antibody Cocktail: Live Updates
AstraZeneca’s Japanese Covid-19 vaccine trial back up, U.S. still paused